Combination chemotherapy with adriamycin andcis-diamminedichloroplatinum in patients with neoplastic diseases

Platinum Compounds: a New Class of Potent Antitumour Agents

1969 • 3,785 citations

Adriamycin

1974 • 1,051 citations

Phase II evaluation of adriamycin in human neoplasia

1973 • 414 citations

Adriamycin chemotherapy—efficacy, safety, and pharmacologic basis of an intermittent single high-dosage schedule

1974 • 393 citations

The successful regression of large solid sarcoma 180 tumors by platinum compounds.

1970 • 372 citations

Diaminodichloroplatinum: A phase I study showing responses in testicular and other tumors

1974 • 286 citations

Proliferation-dependent cytotoxicity of anticancer agents: a review.

1975 • 216 citations

Atopic hypersensitivity to cis-dichlorodiammineplatinum(II) and other platinum complexes.

1975 • 86 citations

Superiority of adriamycin over oral nitrosoureas in patients with advanced breast carcinoma.A southwest cancer chemotherapy study group study

1974 • 63 citations

Inhibition of Dunning asc itic leukemia and Walker 256 carcinosarcoma with cis-diamminedichloroplatinum (NSC-119875).

1970 • 62 citations

Growth Inhibition of Rat Mammary Carcinoma Induced by Cis-Platinum Diamminodichloride-II<xref ref-type="fn" rid="FN1">2</xref><xref ref-type="fn" rid="FN2">3</xref>

1971 • 46 citations

cis-Platinum (II) Diamminedichloride

1974 • 43 citations

Adriamycin in advanced bronchogenic carcinoma

1974 • 36 citations

Phase I Evaluation of cis-Platinum (II) Diamminedichloride (PDD) and a Combination of PDD Plus Adriamycin

1974 • 27 citations

Further Clinical Experience with cis-Platinum (II) Diamminedichloride

1974 • 14 citations